Oncologic Disorders
23
4
4
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
1 terminated out of 23 trials
92.9%
+6.4% vs benchmark
13%
3 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (23)
The Needs and Burden of Family Caregivers of Older Adults With Cancer
LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Advanced Imaging Holistic Omics Biobank
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Hepatitis E Virus Infection in Oncological Patients
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology
The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)
Nutrition Health Literacy of Cancer Patients and Their Support Networks.
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
COVID-19 Vaccination in Oncologic Patients
Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction
Place of General Medical During Oncology Care Management
Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders